日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma

CDK4/6 和 PD-1 序贯抑制后肿瘤和免疫动力学:一项去分化脂肪肉瘤 II 期研究的结果

Rosenbaum, Evan; Gularte-Mérida, Rodrigo; Seffar, Evan; Lee, Jasme; Adamow, Mathew; Bradic, Martina; Dickson, Mark A; Avutu, Viswatej; Banks, Lauren B; Chan, Jason E; Chi, Ping; Gounder, Mrinal M; Kelly, Ciara M; Keohan, Mary Louise; Maki, Robert G; Movva, Sujana; Reed, Damon R; Desir, Rhoena; Biniakewitz, Matthew; Erinjeri, Joseph P; Lefkowitz, Robert A; Wong, Phillip; Antonescu, Cristina R; Qin, Li-Xuan; Panageas, Katherine S; Shen, Ronglai; Singer, Samuel; Koff, Andrew; Tap, William D; D'Angelo, Sandra P

Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma

rucaparib 和 nivolumab 治疗平滑肌肉瘤患者的 II 期研究

Sujana Movva ,Kenneth Seier ,Martina Bradic ,Karmelina Charalambous ,Evan Rosenbaum ,Ciara M Kelly ,Seth M Cohen ,Martee L Hensley ,Viswatej Avutu ,Lauren B Banks ,Jason E Chan ,Ping Chi ,Sandra D'Angelo ,Mark A Dickson ,Mrinal M Gounder ,Mary L Keohan ,Robert G Maki ,Angela Green ,Vicky Makker ,Maria M Rubinstein ,Sara Saunds ,Jae-Mun Cho ,Robert A Lefkowitz ,Joseph Erinjeri ,Li-Xuan Qin ,Ronak Shah ,Phillip Wong ,William Tap

A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer

一项评估氟维司群联合阿贝西利治疗激素受体阳性晚期或复发性子宫内膜癌的II期研究

Green, Angela K; Zhou, Qin; Iasonos, Alexia; Zammarrelli, William A 3rd; Weigelt, Britta; Ellenson, Lora H; Chhetri-Long, Rashmi; Shah, Pooja; Loh, Jade; Hom, Vania; Selenica, Pier; Erinjeri, Joseph; Petkovska, Iva; Chandarlapaty, Sarat; Cohen, Seth; Grisham, Rachel; Konner, Jason; Rubinstein, Maria M; Tew, William; Troso-Sandoval, Tiffany; Aghajanian, Carol; Makker, Vicky

A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma

一项针对晚期肉瘤患者的 I 期研究,评估 CSF1R 抑制剂 vimseltinib 与 PD-L1 抑制剂 avelumab 联合用药的疗效。

E Rosenbaum ,K Seier ,M Bradic ,S Movva ,C M Kelly ,M A Dickson ,M L Keohan ,M M Gounder ,P Chi ,B A Nacev ,J E Chan ,V Avutu ,M Biniakewitz ,S Jasnani ,M Duchemin ,R Desir ,P Wong ,J Erinjeri ,S Hwang ,C R Antonescu ,L-X Qin ,W D Tap ,S P D'Angelo

TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization

TP53突变预示着接受经动脉栓塞治疗的肝细胞癌患者生存期更短和局部进展更早

Zhao, Ken; Karimi, Anita; Kelly, Luke; Petre, Elena; Marinelli, Brett; Alexander, Erica S; Sotirchos, Vlasios S; Erinjeri, Joseph P; Covey, Anne; Sofocleous, Constantinos T; Harding, James J; Jarnagin, William; Sigel, Carlie; Vakiani, Efsevia; Ziv, Etay; Yarmohammadi, Hooman

Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization

DAXX/ATRX蛋白表达缺失导致胰腺神经内分泌肿瘤细胞产生缺血抵抗和放射敏感性,并与经动脉放射栓塞治疗反应改善相关。

Puzzuoli  ; Caleb Solivio,Gavin Yuan,Anthony J Rizzo,Mindy K Graham,Larissa Shenker,Will Vista,Adam Gil,Himanshu Singh,Erica Alexander,Adrian Gonzalez-Aguirre,Jonathan Latzman,E Nadia Petre,Hooman Yarmohammadi,Joseph P Erinjeri,Anne Covey,Eric Chan,James Russell,Lisa Bodei,Nitya Raj,Diane Reidy-Lagunes,Christopher M Heaphy,Etay Ziv

Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization.

DAXX/ATRX 蛋白表达的丧失导致胰腺神经内分泌肿瘤细胞的缺血抵抗和放射敏感性,并且与经动脉放射栓塞治疗反应的改善有关

Puzzuoli Jessica C, Solivio Caleb, Yuan Gavin, Rizzo Anthony J, Graham Mindy K, Shenker Larissa, Vista Will, Gil Adam, Singh Himanshu, Alexander Erica, Gonzalez-Aguirre Adrian, Latzman Jonathan, Petre E Nadia, Yarmohammadi Hooman, Erinjeri Joseph P, Covey Anne, Chan Eric, Russell James, Bodei Lisa, Raj Nitya, Reidy-Lagunes Diane, Heaphy Christopher M, Ziv Etay

HSF-1 promotes longevity through ubiquilin-1-dependent mitochondrial network remodelling

HSF-1通过泛素-1依赖的线粒体网络重塑促进寿命

Annmary Paul Erinjeri, Xunyan Wang, Rhianna Williams, Riccardo Zenezini Chiozzi, Konstantinos Thalassinos, Johnathan Labbadia

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma

针对肉瘤患者的乐伐替尼和帕博利珠单抗组织学特异性临床试验

Movva, Sujana; Seier, Kenneth; Avutu, Viswatej; Banks, Lauren B; Chan, Jason; Chi, Ping; Dickson, Mark A; Gounder, Mrinal M; Kelly, Ciara M; Keohan, Mary L; Maki, Robert; Rosenbaum, Evan; Salcito, Tiffany; Rodriguez, Kaithleen; Dempsey, Rebecca; Meyers, Paul A; Cohen, Seth M; Hensley, Martee L; Konner, Jason A; Schram, Alison M; Lefkowitz, Robert A; Erinjeri, Joseph P; Qin, Li-Xuan; Tap, William D; D'Angelo, Sandra P

Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization

既往接受过经动脉栓塞治疗的肝细胞癌患者接受Y90放射性栓塞治疗的疗效

Zhao, Ken; Son, Sam; Karimi, Anita; Marinelli, Brett; Erinjeri, Joseph P; Alexander, Erica S; Sotirchos, Vlasios S; Harding, James J; Soares, Kevin C; Ziv, Etay; Covey, Anne; Sofocleous, Constantinos T; Yarmohammadi, Hooman